Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, secures a spot on Fortune’s 2025 list of the 100 Most Powerful People in Business, ranking at 62. As the first Indian-origin woman to lead a major US biotech firm, her leadership has propelled Vertex to a $110 billion valuation, marked by innovations like the FDA-approved non-opioid pain treatment, Journavx.
Trending
- ‘Seems fake’: EC asks Tejashwi to surrender ‘false EPIC’; says ‘it is a legal offence’
- ‘India not so unfortunate…’: Owaisi on Netanyahu’s offer to ‘advise’ PM Modi on Trump tariffs; hits out over Gaza war
- At the heart of it all: Demystifying heart surgeries
- ‘Tired script’: Election Commission blasts Rahul Gandhi’s ‘vote theft’ claim; recalls Kamal Nath case of 2018
- ‘Tired script’: EC slams Rahul’s ‘vote theft’ claim; cites 2018 SC decision
- OnlyFans bombshell: Astronomer ex-CEO spent Rs 2.2cr on site; secret chats leaked by wife
- Amid standoff with US, Modi speaks to Putin, says he’ll host him this year
- ‘PM Modi can’t, shouldn’t bend knee to Donald Trump’: US tariffs on India draws rare bipartisan concern in US – watch